Feiling Feng

984 total citations
37 papers, 628 citations indexed

About

Feiling Feng is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Feiling Feng has authored 37 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Surgery and 17 papers in Cancer Research. Recurrent topics in Feiling Feng's work include Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Cancer-related molecular mechanisms research (12 papers) and MicroRNA in disease regulation (6 papers). Feiling Feng is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Cancer-related molecular mechanisms research (12 papers) and MicroRNA in disease regulation (6 papers). Feiling Feng collaborates with scholars based in China, United States and Hong Kong. Feiling Feng's co-authors include Chen Liu, Qingbao Cheng, Bin Yi, Xiaoqing Jiang, Mengchao Wu, Hongyang Wang, Xiangji Luo, Qingxiang Gao, Yan–Xin Chang and Yong Yu and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Feiling Feng

35 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feiling Feng China 15 334 278 211 178 88 37 628
Lun Qin China 6 267 0.8× 242 0.9× 170 0.8× 117 0.7× 59 0.7× 7 532
Zhengchuan Niu China 16 382 1.1× 278 1.0× 120 0.6× 240 1.3× 72 0.8× 29 698
Imane El Dika United States 13 207 0.6× 145 0.5× 81 0.4× 214 1.2× 109 1.2× 30 573
Xing Yao China 14 365 1.1× 175 0.6× 114 0.5× 78 0.4× 53 0.6× 38 554
Brigitte Wolf Austria 16 171 0.5× 167 0.6× 128 0.6× 308 1.7× 87 1.0× 40 616
Yingjun Xie China 11 423 1.3× 366 1.3× 44 0.2× 121 0.7× 76 0.9× 20 623
Emilien Loeuillard United States 9 115 0.3× 101 0.4× 223 1.1× 216 1.2× 43 0.5× 15 479
Changqing Xie United States 14 165 0.5× 119 0.4× 147 0.7× 465 2.6× 116 1.3× 48 745
Boyi Liao China 11 325 1.0× 286 1.0× 93 0.4× 67 0.4× 43 0.5× 13 504
Le Xiao China 13 198 0.6× 68 0.2× 176 0.8× 193 1.1× 86 1.0× 29 529

Countries citing papers authored by Feiling Feng

Since Specialization
Citations

This map shows the geographic impact of Feiling Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiling Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiling Feng more than expected).

Fields of papers citing papers by Feiling Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiling Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiling Feng. The network helps show where Feiling Feng may publish in the future.

Co-authorship network of co-authors of Feiling Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Feiling Feng. A scholar is included among the top collaborators of Feiling Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiling Feng. Feiling Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheng, Renwang, Weikun Li, Yinghua Tao, et al.. (2025). Mannose‐Glycated Metal‐Phenolic Microcapsules Orchestrate Phenotype Switch of Macrophages for Boosting Tumor Immunotherapy. Advanced Science. 12(16). e2415565–e2415565. 2 indexed citations
2.
Li, Weikun, Xin Tan, Yanling Liang, et al.. (2025). Multifunctional microneedle patch synergized with electrical stimulation to regulate microenvironment for enhanced healing of infected diabetic wounds. Chemical Engineering Journal. 505. 159255–159255. 17 indexed citations
3.
Liu, Dan, Yan Xi, Xufeng Chen, et al.. (2024). Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma. Genome Medicine. 16(1). 98–98. 18 indexed citations
4.
Duan, Qiaonan, Weiyi Wang, Feiling Feng, et al.. (2023). Comut-viz: efficiently creating and browsing comutation plots online. BMC Bioinformatics. 24(1). 226–226.
5.
Jiang, Tianyi, Tao Lü, Hui Wang, et al.. (2023). Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma. Frontiers in Immunology. 14. 1166497–1166497. 51 indexed citations
6.
Feng, Feiling, et al.. (2023). Structural changes and anti-hepatocellular carcinoma activity of interferon-γ after interaction with sinensetin. International Journal of Biological Macromolecules. 253(Pt 1). 126392–126392. 1 indexed citations
7.
Feng, Feiling, Qingxiang Gao, Yue Wu, et al.. (2021). Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study. European Journal of Surgical Oncology. 47(9). 2363–2368. 7 indexed citations
8.
Feng, Feiling, Xiaobing Wu, Xiaoliang Shi, et al.. (2021). Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. International Journal of Clinical Oncology. 26(4). 717–727. 11 indexed citations
9.
10.
Feng, Feiling, Huizhen Wang, Qingxiang Gao, et al.. (2020). Establishment and characterization of patient-derived primary cell lines as preclinical models for gallbladder carcinoma. Translational Cancer Research. 9(3). 1698–1710. 2 indexed citations
11.
Feng, Feiling, Qingbao Cheng, Dadong Zhang, et al.. (2020). Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study. Oncology Reports. 43(4). 1089–1102. 2 indexed citations
12.
Lü, Kai, Feiling Feng, Yingcheng Yang, et al.. (2019). High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma. Journal of Gastroenterology. 55(1). 51–66. 20 indexed citations
13.
Feng, Feiling, et al.. (2019). Mutant ACTB mRNA 3′-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a. Cellular Signalling. 67. 109479–109479. 14 indexed citations
14.
Li, Yong, et al.. (2018). Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth. Biochemical and Biophysical Research Communications. 504(4). 654–659. 24 indexed citations
15.
Gao, Qingxiang, et al.. (2018). Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research. 37(1). 29 indexed citations
16.
Huang, Sheng, et al.. (2017). MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer. Tumor Biology. 39(3). 3726130824–3726130824. 12 indexed citations
17.
Chang, Yan–Xin, Chen Liu, Jiahe Yang, et al.. (2013). miR-20a triggers metastasis of gallbladder carcinoma. Journal of Hepatology. 59(3). 518–527. 103 indexed citations
18.
Liu, Chen, Bin Sun, Weifeng Tan, et al.. (2011). Inhibitory effect of Survivin promoter‐regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer. Molecular Oncology. 5(6). 545–554. 29 indexed citations
19.
Yi, Bin, et al.. (2010). Long-term results of surgical treatment in 181 cases of advanced stage gallbladder carcinoma. Zhonghua gan-dan waike zazhi. 16(9). 655–658.
20.
Tan, Weifeng, Yong Yu, Bin Yi, et al.. (2010). Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation. Acta Pharmacologica Sinica. 31(12). 1643–1648. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lun Qin Breakdown of academic impact, for papers by Zhengchuan Niu Breakdown of academic impact, for papers by Imane El Dika Breakdown of academic impact, for papers by Xing Yao Breakdown of academic impact, for papers by Brigitte Wolf Breakdown of academic impact, for papers by Yingjun Xie Breakdown of academic impact, for papers by Emilien Loeuillard Breakdown of academic impact, for papers by Changqing Xie Breakdown of academic impact, for papers by Boyi Liao Breakdown of academic impact, for papers by Le Xiao
Rankless by CCL
2026